Home Heart Disease Treatment Structural Heart Disease Treatment Devices Market Boosted by Growing Prevalence of Heart-related Disorders ...

Structural Heart Disease Treatment Devices Market Boosted by Growing Prevalence of Heart-related Disorders ...

9 min read

LONDON--(BUSINESS WIRE)--Technavio
market research analysts have predicted the global
structural heart disease treatment devices market
to grow at a
CAGR of close to 10% during the period 2018-2022, in their latest
report.

One of the major trends being witnessed in the market is the increase in
product launches coupled with R&D activities. The vendors are
strategically concentrating on the development and commercial launch of
their devices for treating a broad range of structural heart diseases.
New product development and R&D activities assist vendors in retaining
their position in this market and improve their growth. Vendors are
actively involved in launching innovative devices for enhancing clinical
outcomes of LAA closure devices, and transcatheter heart valves such as
the MRI enabled heart valves for increased visualization, and advanced
mechanical heart valves. Additionally, vendors are actively engaged in
R&D activities and they are planning to launch innovative products
during the forecast period.

This report is available at a USD 1,000 discount for a limited time
only:
View
market snapshot before purchasing

Save more with Technavio. Buy 2 reports and get the
third for FREE:
View
all Technavio’s current offers

In this report, Technavio analysts highlight the growing prevalence of
heart-related disorders as a key factor contributing to the growth of
the global structural
heart disease treatment devices
market:

Growing prevalence of heart-related disorders

The prevalence of various chronic heart-related disorders such as
valvular heart diseases, heart failure, cardiac arrest, and congenital
heart defects is increasing at a significant rate across the globe.
Sudden cardiac arrest is the leading cause of death among adults above
40 years, particularly among individuals above 60 years. Besides,
cardio-related disorders such as stroke, rhythm disorders, congenital
heart disease, subclinical atherosclerosis, and peripheral arterial
disease are the other complications demanding surgical intervention to
repair or replace damaged valves and treat damaged or defective areas in
the heart.

According to a senior analyst at Technavio for cardiovascular
devices
, “The incidences of congenital heart defects among
newborns who require surgical or catheterization procedures to correct
damaged heart valves are increasing at a significant rate. On an
average, more than one million newborns are born with CHD each year and
require immediate surgical procedures to correct these birth defects.
Therefore, the growing prevalence of various heart-related disorders
that require improved treatment options such as surgical intervention
increase the demand for various structural heart disease treatment
devices.”

Looking for more information on this market? Request
a free sample report

Technavio’s sample reports are free of charge and contain multiple
sections of the report such as the market size and forecast, drivers,
challenges, trends, and more.

Global structural heart disease treatment
devices market – segmentation analysis

This market research report segments the global structural
heart disease treatment devices
market into the following
products (repair devices and replacement devices) and key regions (the
Americas, APAC, and EMEA). It provides an analysis of the major factors
influencing the market, including drivers, opportunities, trends, and
industry-specific challenges.

The market for repair devices will grow at a rapid rate during the
forecast period owing to the emerging trend of LAA closure devices.
These devices are MI techniques that are used to reduce the occurrences
of heart attack and the risk of entering left atrial appendage blood
clots in the bloodstream. According to a research, closure of the left
atrial appendage during heart surgery protects the brain.

In 2017, the Americas dominated the global structural heart disease
treatment devices market followed by the markets in EMEA and APAC. The
Americas accounted for a market share of approximately 48% in 2017. The
market in the Americas is growing at a significant rate because of the
growing preference for tissue heart valves over mechanical heart valves
and increased adoption of MI and transcatheter procedures.

Save big with Technavio this May!

Find out what companies are venturing in to beat the heat this
summer! Technavio indulges you with a massive 20% OFF on all

non-alcoholic
beverages reports
for the entire month.

OR

Technavio honors the achievements and efforts of Motherhood this
Mother's Day by offering a whopping 30% OFF on all cosmetics
and toiletry reports
. Offer valid from 7th May for a
limited period.

About Technavio

Technavio
is a leading global technology research and advisory company. Their
research and analysis focuses on emerging market trends and provides
actionable insights to help businesses identify market opportunities and
develop effective strategies to optimize their market positions.

With over 500 specialized analysts, Technavio’s report library consists
of more than 10,000 reports and counting, covering 800 technologies,
spanning across 50 countries. Their client base consists of enterprises
of all sizes, including more than 100 Fortune 500 companies. This
growing client base relies on Technavio’s comprehensive coverage,
extensive research, and actionable market insights to identify
opportunities in existing and potential markets and assess their
competitive positions within changing market scenarios.

If you are interested in more information, please contact our media team
at [email protected].

Source link

Leave a Reply

Your email address will not be published. Required fields are marked *

Check Also

HeartFlow Analysis Demonstrates Highest Diagnostic Performance for Detecting Heart Disease Compared to Other ...

PARIS, May 22, 2018 (GLOBE NEWSWIRE) -- HeartFlow, Inc. today announced new data from the …